Wordt geladen...
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia
The BCL11B transcription factor is required for normal T-cell development, and has recently been implicated in the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) induced by TLX overexpression or Atm deficiency. To comprehensively assess the contribution of BCL11B inactivation to human T...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3204734/ https://ncbi.nlm.nih.gov/pubmed/21878675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-11-318873 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|